Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Head and Neck Cancer

Free Subscription 09.03.2026 1 Ann Thorac Surg 4 Anticancer Res 2 BMC Cancer 2 BMC Surg 1 Clin Nucl Med 1 Dis Esophagus 1 Head Neck 3 Int J Cancer 1 Int J Radiat Oncol Biol Phys 1 J Laryngol Otol 7 Oral Oncol 6 Otolaryngol Head Neck Surg 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Thorac Surg

1. JEON YJ, Son JA, Lee J, Park SY, et al
   Prognosis of Isolated Cervical Node Recurrence Following Esophagectomy With Two-Field Lymphadenectomy for Esophageal Squamous Cell Carcinoma.
   Ann Thorac Surg. 2026 Feb 19:S0003-4975(26)00143.
   PubMed         Abstract available
   
   

   
   Anticancer Res

2. KITASAKI N, Hamai Y, Hirohata R, Ohsawa M, et al
   Prediction of Pathological Response and Prognosis After Surgery by Tumor Reduction During Neoadjuvant Chemotherapy in Patients With Esophageal Squamous Cell Carcinoma.
   Anticancer Res. 2026;46:1629-1638.
   PubMed         Abstract available
   
   
3. TSUJI M, Kobayashi K, Kawakami K, Fukuda N, et al
   Real-world Analysis of Urinary Protein-to-Creatinine Ratio and Blood Pressure in Lenvatinib Therapy.
   Anticancer Res. 2026;46:1651-1659.
   PubMed         Abstract available
   
   
4. TAKAHASHI T, Shishido Y, Sakabe T, Orihara J, et al
   Roles of GPX4 and FSP1 in Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemotherapy.
   Anticancer Res. 2026;46:1529-1543.
   PubMed         Abstract available
   
   
5. ATHANASOPOULOS M, Papanikolaou V, Roukas D, Chrysovergis A, et al
   FAS/FAS-ligand Apoptotic Complex Deregulation in Laryngeal Squamous Cell Carcinomas.
   Anticancer Res. 2026;46:1421-1428.
   PubMed         Abstract available
   
   

   
   BMC Cancer

6. SI L, Zhao C, Chard Dunmall LS, Wang P, et al
   Oncolytic adenovirus type 11-induced ferroptosis of esophageal squamous cell carcinoma cells involves in mitochondrial impairment and the mTOR pathway.
   BMC Cancer. 2026 Feb 24. doi: 10.1186/s12885-026-15735.
   PubMed        
   
   
7. SHI J, Liu J, Xu Z, Chen M, et al
   Association of sarcopenia with pathologic complete response in esophageal squamous cell carcinoma patients undergoing neoadjuvant immunochemotherapy.
   BMC Cancer. 2026 Feb 23. doi: 10.1186/s12885-026-15782.
   PubMed        
   
   

   
   BMC Surg

8. XUE M, Wu M, Lu M
   Successful rescue of a patient with aortoesophageal fistula secondary to anastomotic leak after esophagectomy.
   BMC Surg. 2026;26:166.
   PubMed         Abstract available
   
   
9. LI X, Zhang X, Lin Y, Ma Y, et al
   Novel laryngeal preservation technique in postcricoid hypopharyngeal carcinoma: a case-series study.
   BMC Surg. 2026 Mar 4. doi: 10.1186/s12893-026-03586.
   PubMed        
   
   

   
   Clin Nucl Med

10. DHARMASHAKTU Y, Rastogi S, Wakankar R, Shamim SA, et al
    18F-FDG PET/CT Demonstrates Significant Response in Anaplastic Thyroid Carcinoma Treated With Combined Immunotherapy and Targeted Therapy.
    Clin Nucl Med. 2026 Feb 25. doi: 10.1097/RLU.0000000000006207.
    PubMed         Abstract available
    
    

    
    Dis Esophagus

11. RAYNER CJ, Paine H, Luangsomboon A, McGuire A, et al
    Robotic-Assisted Ivor Lewis Esophagectomy (RAILE): a comparative analysis of a single unit, consecutive series of Open, Hybrid, and Robotic approaches.
    Dis Esophagus. 2026;39:doag016.
    PubMed         Abstract available
    
    

    
    Head Neck

12. SINGH AG, Kole L, Sullivan R, Sinha S, et al
    Disparity in the Markers of Affordability Across Targeted- and Immune-Therapy Drugs Used in Head and Neck Cancers.
    Head Neck. 2026 Feb 26. doi: 10.1002/hed.70212.
    PubMed         Abstract available
    
    

    
    Int J Cancer

13. WU H, Li Y, Ran L, Xia Z, et al
    Needle-shaped diatom frustules in food as a possible promoter of esophageal squamous cell carcinoma in coastal southeastern China: A pilot study.
    Int J Cancer. 2026 Feb 23. doi: 10.1002/ijc.70394.
    PubMed         Abstract available
    
    
14. PENG L, Ding X, Zou RC, You R, et al
    Comparison of >/=2 lines immunotherapy regimens for recurrent/metastatic nasopharyngeal carcinoma.
    Int J Cancer. 2026 Feb 23. doi: 10.1002/ijc.70399.
    PubMed         Abstract available
    
    
15. NETHAN ST, Perez-de-Oliveira ME, Campbell F, Santos-Silva AR, et al
    Interventions for oral cancer prevention: An evidence and gap map.
    Int J Cancer. 2026 Feb 23. doi: 10.1002/ijc.70391.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

16. HAN JE, Diplas BH, Paudyal R, Oh JH, et al
    Apparent Diffusion Coefficient Magnetic Resonance Imaging as a Predictive Biomarker for Hypoxia, Treatment De-escalation, and Recurrence in Human Papillomavirus-Associated Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2026;124:1015-1023.
    PubMed         Abstract available
    
    

    
    J Laryngol Otol

17. DRANOVA S
    Beyond the conventional: the efficacy of liquid biopsy in post-therapeutic monitoring of oropharyngeal cancer, a meta-analysis.
    J Laryngol Otol. 2026;140:123-131.
    PubMed         Abstract available
    
    

    
    Oral Oncol

18. MARGONI A, Papavassiliou KA, Papavassiliou AG
    From heterogeneity to molecular stratification: A multiplex genomic panel for tailored therapy of head and neck squamous cell carcinoma.
    Oral Oncol. 2026;175:107904.
    PubMed         Abstract available
    
    
19. ECONOMOPOULOU P, Pouliakis A, Kyprianou M, Pantazopoulos A, et al
    An observational retro-prospective study on patients with head and neck cancer who contracted COVID-19 (HERODOTUS: head and neck cancERs international cOviD-19 collabOraTion).
    Oral Oncol. 2026;175:107900.
    PubMed         Abstract available
    
    
20. HOLGADO A, Llansana A, Vazquez C, Gallego O, et al
    Identification of prognostic variables in patients with recurrent head and neck squamous cell carcinoma treated with salvage surgery: Implications for treatment with immunotherapy.
    Oral Oncol. 2026;175:107903.
    PubMed         Abstract available
    
    
21. BHATI M, Bagchi P, Pawar P, Baviskar P, et al
    Aberrant lateral position of external carotid artery, a surgical pitfall during neck dissection.
    Oral Oncol. 2026;175:107905.
    PubMed        
    
    
22. NTOUKAS SM, Mohamad N, Boparai R, Dennett L, et al
    Effects of exercise on health-related fitness and patient-reported outcomes in survivors of head and neck cancer: a systematic review and meta-analysis.
    Oral Oncol. 2026;175:107902.
    PubMed         Abstract available
    
    
23. ZHAO ZY, He SQ, Liu GY, Lv SH, et al
    Efficacy of radiotherapy to metastatic lesion in de novo metastatic nasopharyngeal carcinoma patients: A multicenter, propensity score matching study.
    Oral Oncol. 2026;175:107907.
    PubMed         Abstract available
    
    
24. SHIMIZU T, Takahashi H, Tada H, Chikamatsu K, et al
    Integrative analysis of aging-related immune parameters reveals prognostic and immunotherapeutic implications in head and neck squamous cell carcinoma.
    Oral Oncol. 2026;176:107914.
    PubMed         Abstract available
    
    

    
    Otolaryngol Head Neck Surg

25. GAO EY, See ASY, Tan BKJ, Chan SWD, et al
    Tonsillar Asymmetry and Malignancy: A Meta-analysis of Diagnostic Accuracy.
    Otolaryngol Head Neck Surg. 2026;174:643-654.
    PubMed         Abstract available
    
    
26. CHANG KW, Peterson AM, Tharakan T, Puram SV, et al
    Outcomes of Minimally Invasive Transoral Surgery in HPV-Negative Oropharyngeal Cancer.
    Otolaryngol Head Neck Surg. 2026;174:765-773.
    PubMed         Abstract available
    
    
27. TUCKER A, Bollig CA
    A National Analysis of Microscopic Positive Margins in Oropharyngeal Cancer Patients Undergoing Transoral Robotic Surgery.
    Otolaryngol Head Neck Surg. 2026;174:756-764.
    PubMed         Abstract available
    
    
28. HATTORI T, Fujii M, Ueda T, Ishikawa A, et al
    Exploration of Therapeutic Targets Using CDK4 Inhibitors for Head and Neck Mucosal Melanoma.
    Otolaryngol Head Neck Surg. 2026;174:784-791.
    PubMed         Abstract available
    
    
29. DUHON BH, Sun X, Hernandez M, Lewis CM, et al
    Outcomes and Risk Factors in Oncologic Temporal Bone Surgery: A Head and Neck-Specific NSQIP Analysis.
    Otolaryngol Head Neck Surg. 2026;174:774-783.
    PubMed         Abstract available
    
    
30. HACK S, Karni RJ
    Ethics in Practice: Immunotherapy at End of Life in Head and Neck Cancer.
    Otolaryngol Head Neck Surg. 2026 Feb 24. doi: 10.1002/ohn.70177.
    PubMed        
    
    

    
    PLoS One

31. KUROKAWA T, Iinuma T, Ebisu H, Yanagidaira T, et al
    A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and alpha-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocol.
    PLoS One. 2026;21:e0342387.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum